Author:
Jiang Tao,Chen Hao,Zheng Jianwei,Du Bin,Yang Baoyu,Liu Qing,Zhong Dongta,Wang Xinli,Wang Han,Lin Mengxin,Lai Jinhuo,Hou Peifeng,Lin Xiaoyan
Funder
Fujian Province
Fujian Medical University Qihang Foundation
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference43 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
2. Chen W-Q, Zheng R-S, Zhang S-W, Zeng H-M, Zou X-N. The incidences and mortalities of major cancers in China, 2010. Chin J Cancer. 2014;33:402–5.
3. Zhang L, Cao F, Zhang G, et al. Trends in and predictions of colorectal cancer incidence and mortality in China From 1990 to 2025. Front Oncol. 2019;9:98.
4. Oonnell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96:1420–5.
5. Van Cutsem E, Oliveira J, ESMO Guidelines Working Group. Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(Suppl 4):61–3.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献